KCLU 88.3FM - 102.3FM - 1340AM

Listen Now Morning Edition 4:00am - 9:00am

Thousand Oaks Based Biotech Giant Acquires Leukemia Drug Maker

Posted on Thursday, January 26, 2012 2:01pm


A Thousand Oaks based biotech giant has made a major acquisition, purchasing a company which owns a promising new drug to treat leukemia.

Amgen is paying $1.2 billion dollars to buy Micromet.  It’s an experimental leukemia drug, and if it’s approved for use, would give the Ventura County based company a major new addition to its already strong drug lineup.  Amgen is paying $11 a share to buy the Maryland-based company.


KCLU Local News

KCLU Featured Stories